New weapon to fight leukemia
EurekAlert (press release) - Washington,DC,USA
In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a ...
See all stories on this topic

upgraded to "hold
newratings.com - USA
... has posted its 2Q07 revenues broadly in-line with the estimates primarily due to milestone payment related to HuMax-CD20/ofatumumab received from GSK. ...
See all stories on this topic

TYSABRI(R) Demonstrates Significant Health-Related Quality-of-Life ...
InfoBolsa - Spain
Improvements for Multiple Sclerosis Patients in Study Published in Annals 20/08/2007 06:00:00 Business Wire US12328X1072 TYSABRI is a treatment approved for ...
See all stories on this topic

NICE gives green light to 3 biologics
BiopharmaReporter.com - London,UK
The National Institute for Health and Clinical Excellence (NICE) recommended yesterday that Tysabri (natalizumab) be made available on the National Health ...
See all stories on this topic